Study of the involvement of allogeneic MSCs in bone formation using the model of transgenic mice.
Mesenchymal stem cells (MSCs) are thought to be the most attractive type of cells for bone repair. However, much still remains unknown about MSCs and needs to be clarified before this treatment can be widely applied in the clinical practice. The purpose of this study was to establish the involvement of allogeneic MSCs in the bone formation in vivo, using a model of transgenic mice and genetically labeled cells. Polylactide scaffolds with hydroxyapatite obtained by surface selective laser sintering were used. The scaffolds were sterilized and individually seeded with MSCs from the bone marrow of 5-week-old GFP(+) transgenic C57/Bl6 or GFP(-)C57/Bl6 mice. 4-mm-diameter critical-size defects were created on the calvarial bone of mice using a dental bur. Immediately after the generation of the cranial bone defects, the scaffolds with or without seeded cells were implanted into the injury sites. The cranial bones were harvested at either 6 or 12 weeks after the implantation. GFP(+) transgenic mice having scaffolds with unlabeled MSCs were used for the observation of the host cell migration into the scaffold. GFP(-) mice having scaffolds with GFP(+)MSCs were used to assess the functioning of the seeded MSCs. The obtained data demonstrated that allogeneic MSCs were found on the scaffolds 6 and 12 weeks post-implantation. By week 12, a newly formed bone tissue from the seeded cells was observed, without an osteogenic pre-differentiation. The host cells did not appear, and the control scaffolds without seeded cells remained empty. Besides, a possibility of vessel formation from seeded MSCs was shown, without a preliminary cell cultivation under controlled conditions.
a Institute of Biomedical Technologies, Nizhny Novgorod State Medical Academy , Nizhny Novgorod , Russia.|b Institute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod , Nizhny Novgorod , Russia.
Daria
D
Kuznetsova
a Institute of Biomedical Technologies, Nizhny Novgorod State Medical Academy , Nizhny Novgorod , Russia.
Natalia
N
Prodanets
b Institute of Biology and Biomedicine, Lobachevsky State University of Nizhny Novgorod , Nizhny Novgorod , Russia.
Svetlana
S
Rodimova
c Institute of Laser and Information Technologies, Russian Academy of Sciences , Troitsk , Russia.
Evgeny
E
Antonov
a Institute of Biomedical Technologies, Nizhny Novgorod State Medical Academy , Nizhny Novgorod , Russia.
Aleksandra
A
Meleshina
d Sechenov First Moscow State Medical University, Research Institute for Uronephrology and Reproductive Health , Moscow , Russia.
Peter
P
Timashev
a Institute of Biomedical Technologies, Nizhny Novgorod State Medical Academy , Nizhny Novgorod , Russia.
Elena
E
Zagaynova
D000818:Animals; D002454:Cell Differentiation / Q000235:genetics*; D006801:Humans; D059630:Mesenchymal Stem Cells; D051379:Mice; D008822:Mice, Transgenic; D010012:Osteogenesis / Q000235:genetics*; D023822:Tissue Engineering; D054457:Tissue Scaffolds
GFP; Mesenchymal stem cells; bone formation; fluorescence imaging; transgenic mice